Yuhan Corp Preferred (000105) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yuhan Corp Preferred (000105) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.15 Billion ≈ $25.18 Million USD) by net assets (₩2.34 Trillion ≈ $1.59 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Yuhan Corp Preferred (000105) total market value for the company's overall valuation and market capitalisation.
Yuhan Corp Preferred - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Yuhan Corp Preferred's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yuhan Corp Preferred Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yuhan Corp Preferred ranked by their cash flow conversion efficiency. Explore 000105 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Peoplein Ltd
AU:PPE
|
-0.001x |
|
Awilco LNG ASA
OL:ALNG
|
0.032x |
|
SelfWealth Limited
AU:SWF
|
0.093x |
|
BII Railway Transportation Technology Holdings Company Limited
F:CN6
|
-0.008x |
|
GSD Denizcilik Gayrimenkul Insaat Sanayi ve Ticaret AS
IS:GSDDE
|
0.030x |
|
NextSource Materials Inc
TO:NEXT
|
-0.143x |
|
Ssangyong Information & Communications Corp
KQ:010280
|
-0.143x |
|
Fuel Tech Inc
NASDAQ:FTEK
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Yuhan Corp Preferred (2014–2025)
The table below shows the annual cash flow conversion efficiency of Yuhan Corp Preferred from 2014 to 2025. View current stock price of Yuhan Corp Preferred for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩2.36 Trillion ≈ $1.60 Billion |
₩106.23 Billion ≈ $71.99 Million |
0.045x | +77.12% |
| 2024-12-31 | ₩2.15 Trillion ≈ $1.46 Billion |
₩54.60 Billion ≈ $37.00 Million |
0.025x | -60.58% |
| 2023-12-31 | ₩1.98 Trillion ≈ $1.34 Billion |
₩127.75 Billion ≈ $86.58 Million |
0.064x | +29.92% |
| 2022-12-31 | ₩2.01 Trillion ≈ $1.36 Billion |
₩99.53 Billion ≈ $67.45 Million |
0.050x | -3.07% |
| 2021-12-31 | ₩1.94 Trillion ≈ $1.31 Billion |
₩99.00 Billion ≈ $67.09 Million |
0.051x | +227.54% |
| 2020-12-31 | ₩1.85 Trillion ≈ $1.25 Billion |
₩28.83 Billion ≈ $19.54 Million |
0.016x | -60.96% |
| 2019-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
₩65.99 Billion ≈ $44.72 Million |
0.040x | -29.32% |
| 2018-12-31 | ₩1.65 Trillion ≈ $1.12 Billion |
₩93.45 Billion ≈ $63.33 Million |
0.057x | -27.94% |
| 2017-12-31 | ₩1.61 Trillion ≈ $1.09 Billion |
₩126.13 Billion ≈ $85.47 Million |
0.079x | +58.48% |
| 2016-12-31 | ₩1.50 Trillion ≈ $1.01 Billion |
₩74.14 Billion ≈ $50.25 Million |
0.050x | -46.47% |
| 2015-12-31 | ₩1.36 Trillion ≈ $924.32 Million |
₩126.23 Billion ≈ $85.55 Million |
0.093x | +25.11% |
| 2014-12-31 | ₩1.28 Trillion ≈ $864.64 Million |
₩94.39 Billion ≈ $63.96 Million |
0.074x | -- |
About Yuhan Corp Preferred
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more